These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5291093)

  • 21. [Study of the biological characteristics of strains of M. tuberculosis resistant to isoniazid and rifampin].
    Diaconescu C; Iacob L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(2):151-62. PubMed ID: 6093222
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of endotoxin on the pharmacokinetics of rifampicin in rabbits.
    Lefebvre R; Celeda L; Morávek J; Hofman J; Rasková H
    Physiol Bohemoslov; 1983; 32(4):382-4. PubMed ID: 6353451
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A; Bergogne-Berezin E; Lafaix C
    Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antitubercular activity and pharmacokinetics of rifampicin].
    Ginzburg TS; Drabkina RO
    Antibiotiki; 1972 Jul; 17(7):607-11. PubMed ID: 4655011
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent investigations on the biological properties of rifampicin.
    Furesz S
    Acta Tuberc Pneumol Belg; 1969; 60(3):266-9. PubMed ID: 5371663
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacokinetics of rifomycin].
    Curci G; Ninni A; Iodice F
    Acta Tuberc Pneumol Belg; 1969; 60(3):276-87. PubMed ID: 5371665
    [No Abstract]   [Full Text] [Related]  

  • 27. Study on rifampicin. I. Penetration into the bone in man after single dose of 750 mg.
    Vacek V; Hejzlar M; Pavlansky R
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):217-9. PubMed ID: 4917426
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacokinetics of rifampicin in gastrectomized persons (author's transl)].
    Biehl T; Petersen KF
    Prax Klin Pneumol; 1978 Sep; 32(9):584-92. PubMed ID: 693453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.
    Furesz S; Scotti R; Pallanza R; Mapelli E
    Arzneimittelforschung; 1967 May; 17(5):534-7. PubMed ID: 5631581
    [No Abstract]   [Full Text] [Related]  

  • 30. Interference of isonicotinyl hydrazone in the microbiological analysis of rifampicin from anti-tuberculosis FDC products containing isoniazid.
    Mariappan TT; Geetha T; Pandey R; Jindal KC; Singh S
    J Pharm Biomed Anal; 2004 Nov; 36(3):643-7. PubMed ID: 15522543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
    Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
    Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of rifampin and isoniazid on the pharmacokinetics of diazepam in rabbits].
    Long CF; Zhang Y; Lou YC
    Yao Xue Xue Bao; 1997 Jul; 32(7):481-4. PubMed ID: 11596270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of agar diffusion method for separate determination of concentration of streptomycin and rifampicin in the blood in the presence of isoniazid].
    Zeliger LR; Kivman GIa; Makarova RA; Chaĭkovskaia SM
    Antibiotiki; 1982 Mar; 27(3):173-6. PubMed ID: 6807194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental and clinical studies on the metabolic fate of rifampicin in animals and in humans.
    Yokosawa A; Arai H; Sato H; Motomiya M; Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1973 Dec; 19(4):177-82. PubMed ID: 4768318
    [No Abstract]   [Full Text] [Related]  

  • 35. [Correlations between the biological properties and structure of rifampicin].
    Sensi P
    G Ital Mal Torace; 1969; ():Suppl 2:40-9. PubMed ID: 5357138
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of isoniazid on the distribution of protein-bound iodine in subcellualar fractions and organs in experimental studies].
    Pilko NA; Izhboldina LK
    Probl Tuberk; 1976 Sep; (9):84-5. PubMed ID: 1013120
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rifampicin therapy: data on the pharmacodynamics of the antibiotic derived from clinical practice].
    Angeli G; Pomarelli P
    Clin Ter; 1975 Jun; 73(5):461-4. PubMed ID: 1139866
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
    Isakova ZhT
    Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular growth and drug susceptibility of Mycobacterium tuberculosis in macrophages.
    Chanwong S; Maneekarn N; Makonkawkeyoon L; Makonkawkeyoon S
    Tuberculosis (Edinb); 2007 Mar; 87(2):130-3. PubMed ID: 16860611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.